These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. Basu S; Alavi A J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112 [No Abstract] [Full Text] [Related]
26. Design and manufacture of monoclonal antibodies for radioimmunotherapy. Hale G; Berrie E; Bird P Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789 [TBL] [Abstract][Full Text] [Related]
27. Implementation of a national metrology network of radionuclides used in nuclear medicine. dos Santos JA; Iwahara A; Nícoli IG; Corrêa RS; Alabarse FG; dos Santos CE; Xavier AM; Garcia EJ; Tauhata L; Lopes RT Appl Radiat Isot; 2006; 64(10-11):1114-8. PubMed ID: 16549360 [TBL] [Abstract][Full Text] [Related]
28. Proficiency tests in the determination of activity of radionuclides in radiopharmaceutical products measured by nuclear medicine services in 8 years of comparison programmes in Brazil. Tauhata L; Iwahara A; de Oliveira AE; Rezende EA; Delgado JU; da Silva CJ; Dos Santos JA; Nícoli IG; Alabarse FG; Xavier AM Appl Radiat Isot; 2008; 66(6-7):981-7. PubMed ID: 18346902 [TBL] [Abstract][Full Text] [Related]
29. Heart abscess revealed by nuclear medicine imaging. Förster M; Conradi S; Müller D; Kluge R; Sabri O Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):249. PubMed ID: 15449045 [No Abstract] [Full Text] [Related]
30. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development. Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250 [TBL] [Abstract][Full Text] [Related]
31. Preparation of (90)YCl(3) radiopharmaceutical precursor for nuclear medicine using technology of centrifugal extractors. Srank J; Melichar F; Filyanin AT; Tomes M; Beran M Appl Radiat Isot; 2010 Dec; 68(12):2163-8. PubMed ID: 20692176 [TBL] [Abstract][Full Text] [Related]
32. Recombinant therapeutic monoclonal antibodies: mechanisms of action in relation to structural and functional duality. Congy-Jolivet N; Probst A; Watier H; Thibault G Crit Rev Oncol Hematol; 2007 Dec; 64(3):226-33. PubMed ID: 17716905 [TBL] [Abstract][Full Text] [Related]
33. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279 [TBL] [Abstract][Full Text] [Related]
34. Spatial dose mapping for individualizing radioiodine treatment. Lassmann M; Hänscheid H J Nucl Med; 2007 Jan; 48(1):2-4. PubMed ID: 17204691 [No Abstract] [Full Text] [Related]
35. Effect of smear method on detection of 99mTc radiopharmaceuticals. Kawano T; Ebihara H Health Phys; 1989 Apr; 56(4):543-6. PubMed ID: 2925395 [No Abstract] [Full Text] [Related]
36. Tracers and methods of nuclear medicine. Britton KE Clin Physiol; 1990 May; 10(3):281-5. PubMed ID: 2190747 [No Abstract] [Full Text] [Related]
37. Nuclear medicine and clinical chemistry departments. Harding LK; Smith NB; Bignell A; Thomson WH Nucl Med Commun; 1987 Oct; 8(10):767-9. PubMed ID: 3431758 [No Abstract] [Full Text] [Related]
38. Synthesis and characterization of novel 99gTc(V) and Re(V) complexes with water-soluble tetraaza diamido dipyridino ligands: single-crystal X-ray structural investigations of mono- and dinuclear complexes. Kurti L; Papagiannopoulou D; Papadopoulos M; Pirmettis I; Raptopoulou CP; Terzis A; Chiotellis E; Harmata M; Kuntz RR; Pandurangi RS Inorg Chem; 2003 May; 42(9):2960-7. PubMed ID: 12716188 [TBL] [Abstract][Full Text] [Related]